Deardorff WJ

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease - Nieto_2016_Expert.Opin.Pharmacother_17_861
Author(s) : Nieto RA , Deardorff WJ , Grossberg GT
Ref : Expert Opin Pharmacother , 17 :861 , 2016
Abstract : Nieto_2016_Expert.Opin.Pharmacother_17_861
ESTHER : Nieto_2016_Expert.Opin.Pharmacother_17_861
PubMedSearch : Nieto_2016_Expert.Opin.Pharmacother_17_861
PubMedID: 26918774

Title : Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease - Deardorff_2016_Expert.Opin.Pharmacother__1
Author(s) : Deardorff WJ , Grossberg GT
Ref : Expert Opin Pharmacother , :1 , 2016
Abstract : Deardorff_2016_Expert.Opin.Pharmacother__1
ESTHER : Deardorff_2016_Expert.Opin.Pharmacother__1
PubMedSearch : Deardorff_2016_Expert.Opin.Pharmacother__1
PubMedID: 27450461

Title : The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease - Deardorff_2015_Drugs.Aging_32_537
Author(s) : Deardorff WJ , Feen E , Grossberg GT
Ref : Drugs & Aging , 32 :537 , 2015
Abstract : Deardorff_2015_Drugs.Aging_32_537
ESTHER : Deardorff_2015_Drugs.Aging_32_537
PubMedSearch : Deardorff_2015_Drugs.Aging_32_537
PubMedID: 26033268

Title : Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication - Deardorff_2015_Expert.Rev.Neurother_15_7
Author(s) : Deardorff WJ , Shobassy A , Grossberg GT
Ref : Expert Rev Neurother , 15 :7 , 2015
Abstract : Deardorff_2015_Expert.Rev.Neurother_15_7
ESTHER : Deardorff_2015_Expert.Rev.Neurother_15_7
PubMedSearch : Deardorff_2015_Expert.Rev.Neurother_15_7
PubMedID: 25495510